Urinary neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury in sepsis patients in the emergency department
- 6 June 2019
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 495, 552-555
- https://doi.org/10.1016/j.cca.2019.06.005
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsisClinical Biochemistry, 2013
- AKI in the ICU: definition, epidemiology, risk stratification, and outcomesKidney International, 2012
- ForewordKidney International Supplements, 2012
- Oliguria as predictive biomarker of acute kidney injury in critically ill patientsCritical Care, 2011
- Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injuryIntensive Care Medicine, 2010
- Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalinPediatric Nephrology, 2009
- A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injuryNephrology Dialysis Transplantation, 2009
- Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney DamageAmerican Journal of Kidney Diseases, 2008
- Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shockCritical Care Medicine, 2008
- Studies of the release and turnover of a human neutrophil lipocalinScandinavian Journal of Clinical and Laboratory Investigation, 1995